Market Cap 1.98B
Revenue (ttm) 0.00
Net Income (ttm) -317.42M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.17
Volume 3,008,600
Avg Vol 2,746,604
Day's Range N/A - N/A
Shares Out 142.26M
Stochastic %K 99%
Beta 1.09
Analysts Strong Sell
Price Target $35.35

Company Profile

Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. It is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therap...

Industry: Biotechnology
Sector: Healthcare
Phone: 781 786 8230
Fax: 781 786 8866
Address:
1560 Trapelo Road, Waltham, United States
foghornL
foghornL Oct. 9 at 2:44 AM
0 · Reply
PremarketAnalysis
PremarketAnalysis Oct. 9 at 12:15 AM
$DYN continuation with momentum holding across intervals. SignalEngine: Bullish influence, Algo Vol 93%, Organic Vol 7%, BRX 20%. Algo Intent: natural expansion under sustained volume pressure, monitoring liquidity zone near 14.8 for exhaustion or continuation setup. Momentum Feed: premarketanalysis.com/#momentum=DYN
0 · Reply
Robcfg
Robcfg Oct. 6 at 11:26 PM
$DYN get in before it takes off. 1.8B market cap AV 2.7M+
0 · Reply
intratio
intratio Oct. 2 at 3:53 PM
Market intel: $DYN shows severe selling pressure (-3.9%) paired with material deterioration risk (-1203bp). Momentum decay reinforcing breakdown risk.
0 · Reply
cantare
cantare Sep. 29 at 5:34 PM
$DYN blood bath
0 · Reply
DeepFknValue
DeepFknValue Sep. 24 at 3:51 AM
$DYN IYKYK
0 · Reply
ChristopherBrecher
ChristopherBrecher Sep. 22 at 6:28 PM
$DYN Here is another one. I hope you find these helpful! Let me if you ever want a learning video of how I find these.
1 · Reply
SeanTims337
SeanTims337 Sep. 21 at 10:00 AM
$DYN Energy midstream exposure. Oil price correlation. Dividend yield support. Cyclical industry.
0 · Reply
SwissBull7
SwissBull7 Sep. 11 at 10:21 PM
$SRPT $DYN $NVS diamond sponsors at the World Muscle in Vienna (Austria) from 7th-11th October 2024 On September 26, 2024, Sarepta put out a PR titled “Sarepta Therapeutics to Present New Data from its Neuromuscular Portfolio at 2024 World Muscle Society Congress.” Expect a similar press release this year around September 25–26. On the data sets SRP-1001 and SRP-1003 presented at the 11.October 2025 🚀 https://www.wms2025.com/page/sponsor-wms-2025
0 · Reply
Trainguy1
Trainguy1 Sep. 8 at 2:40 PM
$AVXL I just finished listening to the $DYN Wainwright presentation. It was an audio only Q&A session. So I changed my mind about Anavex’s presentation tomorrow afternoon - I think Anavex’s session will likely be audio only, with Ram Selvaraju asking the questions, and Chris responding. FYI - I entered a couple questions in the Wainwright chat during $DYN’s presentation, but my questions weren’t responded to. Ram hasn’t participated in Anavex’s recent earnings calls, so I hope he doesn’t only ask old questions.
1 · Reply
Latest News on DYN
Dyne Therapeutics to Present at Upcoming Investor Conferences

Aug 27, 2025, 7:30 AM EDT - 6 weeks ago

Dyne Therapeutics to Present at Upcoming Investor Conferences


Satellos Appoints Dr. Wildon Farwell as Chief Medical Officer

Jul 16, 2025, 7:00 AM EDT - 3 months ago

Satellos Appoints Dr. Wildon Farwell as Chief Medical Officer


Dyne Therapeutics to Present at Stifel 2025 Virtual CNS Forum

Mar 11, 2025, 7:30 AM EDT - 7 months ago

Dyne Therapeutics to Present at Stifel 2025 Virtual CNS Forum


foghornL
foghornL Oct. 9 at 2:44 AM
0 · Reply
PremarketAnalysis
PremarketAnalysis Oct. 9 at 12:15 AM
$DYN continuation with momentum holding across intervals. SignalEngine: Bullish influence, Algo Vol 93%, Organic Vol 7%, BRX 20%. Algo Intent: natural expansion under sustained volume pressure, monitoring liquidity zone near 14.8 for exhaustion or continuation setup. Momentum Feed: premarketanalysis.com/#momentum=DYN
0 · Reply
Robcfg
Robcfg Oct. 6 at 11:26 PM
$DYN get in before it takes off. 1.8B market cap AV 2.7M+
0 · Reply
intratio
intratio Oct. 2 at 3:53 PM
Market intel: $DYN shows severe selling pressure (-3.9%) paired with material deterioration risk (-1203bp). Momentum decay reinforcing breakdown risk.
0 · Reply
cantare
cantare Sep. 29 at 5:34 PM
$DYN blood bath
0 · Reply
DeepFknValue
DeepFknValue Sep. 24 at 3:51 AM
$DYN IYKYK
0 · Reply
ChristopherBrecher
ChristopherBrecher Sep. 22 at 6:28 PM
$DYN Here is another one. I hope you find these helpful! Let me if you ever want a learning video of how I find these.
1 · Reply
SeanTims337
SeanTims337 Sep. 21 at 10:00 AM
$DYN Energy midstream exposure. Oil price correlation. Dividend yield support. Cyclical industry.
0 · Reply
SwissBull7
SwissBull7 Sep. 11 at 10:21 PM
$SRPT $DYN $NVS diamond sponsors at the World Muscle in Vienna (Austria) from 7th-11th October 2024 On September 26, 2024, Sarepta put out a PR titled “Sarepta Therapeutics to Present New Data from its Neuromuscular Portfolio at 2024 World Muscle Society Congress.” Expect a similar press release this year around September 25–26. On the data sets SRP-1001 and SRP-1003 presented at the 11.October 2025 🚀 https://www.wms2025.com/page/sponsor-wms-2025
0 · Reply
Trainguy1
Trainguy1 Sep. 8 at 2:40 PM
$AVXL I just finished listening to the $DYN Wainwright presentation. It was an audio only Q&A session. So I changed my mind about Anavex’s presentation tomorrow afternoon - I think Anavex’s session will likely be audio only, with Ram Selvaraju asking the questions, and Chris responding. FYI - I entered a couple questions in the Wainwright chat during $DYN’s presentation, but my questions weren’t responded to. Ram hasn’t participated in Anavex’s recent earnings calls, so I hope he doesn’t only ask old questions.
1 · Reply
kshonstocks
kshonstocks Sep. 5 at 6:30 PM
$DYN more hods, acting well today
1 · Reply
Jewstock
Jewstock Sep. 5 at 2:05 PM
0 · Reply
ScottySalmon
ScottySalmon Sep. 5 at 2:04 PM
$DYN had a dabble first thing. Will take another look in Nov/Dec to see how getting on
0 · Reply
Breck100
Breck100 Aug. 28 at 5:21 PM
$DYN As of 8/25/25. I'm jumping in.
0 · Reply
Jewstock
Jewstock Aug. 28 at 2:07 PM
$DYN go dyn go dyn
0 · Reply
JazzyJ03
JazzyJ03 Aug. 27 at 5:25 PM
$DYN ODD FST BTD DYNE-251 PH1/2 late 2025 DYNE-101 PH1/2 H1 2026
0 · Reply
Jewstock
Jewstock Aug. 25 at 4:18 PM
$DYN bought 17.5c 3/20/26
0 · Reply
Ohzipit
Ohzipit Aug. 25 at 3:11 PM
$DYN see below!
0 · Reply
JarvisFlow
JarvisFlow Aug. 25 at 2:48 PM
Raymond James has updated their rating for Dyne Therapeutics ( $DYN ) to Strong Buy with a price target of 35.
1 · Reply
Sam201
Sam201 Aug. 25 at 2:14 PM
$DYN told you all to load. Sold some more now. Rest above 18 ish!
1 · Reply
Jewstock
Jewstock Aug. 25 at 1:58 PM
$DYN anyone buying calls here?
0 · Reply
Jewstock
Jewstock Aug. 25 at 1:48 PM
$DYN go dyn!
0 · Reply